How Do the New Definitions for Multidrug-Resistant Tuberculosis Treatment Outcomes Really Perform?
Am J Respir Crit Care Med
.
2015 Jul 1;192(1):117.
doi: 10.1164/rccm.201503-0517LE.
Authors
Agnes Gebhard
1
,
Susan van den Hof
1
2
3
,
Frank Cobelens
1
2
3
Affiliations
1
1 KNCV (Royal Netherlands Anti-TB Association) Tuberculosis Foundation The Hague, the Netherlands.
2
2 Department of Global Health, Academic Medical Center Amsterdam, the Netherlands and.
3
3 Amsterdam Institute for Global Health and Development Amsterdam, the Netherlands.
PMID:
26131997
DOI:
10.1164/rccm.201503-0517LE
No abstract available
Publication types
Letter
Comment
MeSH terms
Antitubercular Agents / therapeutic use*
Female
Humans
Male
Microbial Sensitivity Tests*
Mycobacterium tuberculosis / drug effects*
Tuberculosis, Multidrug-Resistant / drug therapy*
Substances
Antitubercular Agents